Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. - Wikidata - awgldk - TriplyDB

Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

http://www.wikidata.org/entity/Q33723082

about

Management of intracerebral hemorrhage--use of statins Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage Emerging risk biomarkers in cardiovascular diseases and disorders Cerebral microhemorrhages: mechanisms, consequences, and prevention.Association of Gallbladder Polyp and Stroke: A Nationwide, Population-Based Study.Quantitative assessment and correlation analysis of cerebral microbleed distribution and leukoaraiosis in stroke outpatients.Brain health and shared risk factors for dementia and stroke.Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment.Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype.Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study.Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection.Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study Statins and risk of poststroke hemorrhagic complications.Cerebral Microbleeds as Predictors of Mortality: The Framingham Heart Study.Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study.Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study.Statin Therapy and the Development of Cerebral Amyloid Angiopathy--A Rodent in Vivo Approach.APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage Early life characteristics and late life burden of cerebral small vessel disease in the Lothian Birth Cohort 1936.Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study.Rapidly Sequential and Fatal Hemorrhaging in a Case of Cerebral Amyloid Angiopathy.Oral Cnm-positive Streptococcus Mutans Expressing Collagen Binding Activity is a Risk Factor for Cerebral Microbleeds and Cognitive Impairment.Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.Epigenetic considerations of the APOE gene. [corrected].Hypercholesterolemia induced cerebral small vessel disease The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.Guidelines for Management of Hyperlipidemia: Implications for Treatment of Patients with Stroke Secondary to Atherosclerotic Disease.Putative Cerebral Microbleeds in Dogs Undergoing Magnetic Resonance Imaging of the Head: A Retrospective Study of Demographics, Clinical Associations, and Relationship to Case Outcome.Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.The impact of cerebrovascular aging on vascular cognitive impairment and dementia.Iatrogeny of Alzheimer's disease: A view point.Cerebral Microbleeds and Cerebrovascular Reactivity in the General Population: The EDAN Study.ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly.APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds.Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).

P2860

Q26752952-43B44639-6184-457C-8504-DD83596E00CB Q28077605-F9EFB9E8-AC69-4FD2-B12B-C488CA0B6F79 Q28081614-EB403524-5412-4599-AFF4-92A37426ADA7 Q30235220-4B53B72E-AC5F-4C6D-BAB4-BBE0BC076A39 Q30396241-F8D1DD5B-7AD2-4612-8BBE-081E4F7874A7 Q30932516-C1272A61-5832-4933-AE7F-0F4B62D3C81A Q31007958-B4DCB740-F53B-419C-B957-9CBBF9604F0E Q31108748-5BF2550B-F573-4BCE-B4E4-E73CA5E7054E Q33638938-DE7E76B8-81B5-4E25-9EAA-7971E90AA50E Q33830165-D2F678C5-ADC1-42CF-B1AD-44E3526921FB Q35134908-0EC626C9-31D7-49EC-9FB7-760E0F4DF85B Q35527193-50F7C773-7F31-441D-848D-8775E1D478FA Q35738024-11C781D1-5F14-465E-8F62-064CCDBD9610 Q35963575-67710DA5-D35B-46E8-AD0B-D05362F82F8C Q35970842-68ECDC6A-07E4-4AE4-881A-8B20AD0BEA77 Q36265888-08C7CD09-FB4E-4209-B54C-95D2B7F432D2 Q36324554-A0D96419-CEA5-4FF4-B504-D94518540144 Q36366572-F8E75E53-9106-44C5-BAB2-F93705BF3653 Q36421107-C09D0E06-AC5C-449B-BDD5-4A51D2AE79CE Q36512688-5E8B8AB5-BC90-4698-82CC-9462F4E31834 Q37074302-5DAEF5AC-525A-494B-BE06-D7039D981F5A Q37361043-994E7EF9-CCB9-4F6E-A9D2-8009DDB4CE23 Q37364397-B2E6AB30-16F4-4E1A-B6F2-50AC15C398E0 Q37423179-43FAAF43-FFD4-484C-B1CE-D24471A8E2EA Q37488056-C4381999-3E73-4ED8-B7F5-5C1A262A9F8B Q37715160-B422B879-23DC-40C1-8183-5117DCB720E0 Q38367862-2644AA68-6AAE-4187-9526-D83AADF98946 Q38630400-9723B64F-F143-425F-8B4B-0A0B633C9544 Q38636940-8959657C-8552-4E8E-BB1E-F3F74F02AA7C Q38720697-09ABF287-98DB-44EF-A72B-CA94914F0AB5 Q38757293-E8972DD0-75B7-4787-B735-842EC1D2A528 Q38876770-4ACD2977-9B54-44F6-94C5-721D5F46AF58 Q38969718-83340B73-2BCF-4FC2-A975-2B015D148E30 Q38974004-A320C814-B6E9-4BDE-BBE4-30F44C950695 Q39779162-9BCCE61D-C1DA-4E20-89D7-9F7CD20BFC94 Q40578810-E85BB3B6-A5FF-4EA1-8D27-52798F020A40 Q41449908-2613BD85-7274-457F-8D71-7229B403884D Q46535385-77245823-D3D4-469A-BB69-83E0E827A2D1 Q47560053-2A70B275-872D-40D3-892A-D6E9A272B294 Q48025023-A6F17BDE-BB57-4480-8B96-7946476B8967

P2860

Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

http://www.wikidata.org/entity/Q33723082

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@ast

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@en

type

label

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@ast

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@en

prefLabel

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@ast

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@en

P1433

Q33723082-6156EDFB-334F-40B4-9E57-D94E328298DE

P1476

Q33723082-4B372DC1-6047-465D-AA33-FD49D5FABB71

P2093

Q33723082-3116B479-7913-4C25-8718-E133BB34F526

Q33723082-74181FD5-EAF3-4857-B77A-4FF99E50EAE8

Q33723082-93AAD86E-AD80-4713-B6A7-90D5917A21D1

Q33723082-E857F75F-B85F-4B2B-8355-BC17799B1AB7

Q33723082-EA576A37-F258-4DC7-A5D7-28569D575C19

Q33723082-FB6D6B1F-193B-41DC-A68A-C12715EE9877

P2860

Q33723082-02FF1F89-227E-4306-A0C3-C5C00FCC57F5

Q33723082-0DBB2A57-F56A-48DB-8252-C48BEB0326DE

Q33723082-1A566B66-2810-425D-875D-B7AF2935D75D

Q33723082-2B14C873-3012-469C-941A-0DBE0875ACE9

Q33723082-5C9B6707-364C-4AD5-BA68-685C3D27E236

Q33723082-6B63A914-9C5F-4CD0-9C8F-9100E4C70012

Q33723082-73465602-0310-4C41-8C6D-A6075D82C508

Q33723082-7D781458-0E69-4DB7-ACC2-8212CFE526F4

Q33723082-7E7EB0BA-6930-46AD-B9DF-F58EBFAAE793

Q33723082-A48F62E6-815D-435A-A7B1-096D4E79AAB7

P304

Q33723082-8B3D9FEB-1970-4299-8666-0A67CBDAF63E

P31

Q33723082-F02B4FE3-8441-4F11-8E55-2E26C50E74EC

P356

Q33723082-EC864159-47D9-4F47-8725-ED5C78CD3624

P407

Q33723082-2C296AA8-DA7D-4ABA-8C29-806D014C29A5

P433

Q33723082-3A90161D-4900-4B6D-95D0-20498A99C726

P478

Q33723082-C80D4435-2493-4A84-B308-6E12197498B7

P50

Q33723082-177FD850-8D6C-44B2-A90D-80284337B6F8

Q33723082-63DDC878-7636-45E0-8623-4A93CFAEBB7A

Q33723082-7EF0B4D7-3A9A-46A0-B9EC-58C13D8CF91F

P577

Q33723082-E26F5808-6248-4084-8F5E-19BBB4F14D48

P5875

Q33723082-54624354-5B7D-4278-A81E-E00A6D5EA0C4

P698

Q33723082-105635E6-C3F5-4F4A-8846-5AD4D7481384

P932

Q33723082-4100023C-BD0E-4197-9D0E-E201362439FB

P356

STROKEAHA.114.004130

P1433

P1476

Risk factors, stroke preventio ...... in the Framingham Heart Study.

@en

P2093

Anand Viswanathan

http://www.w3.org/2001/XMLSchema#string

Carlos S Kase

http://www.w3.org/2001/XMLSchema#string

José Rafael Romero

http://www.w3.org/2001/XMLSchema#string

Philip A Wolf

http://www.w3.org/2001/XMLSchema#string

Sarah R Preis

http://www.w3.org/2001/XMLSchema#string

Sergi Martinez-Ramirez

http://www.w3.org/2001/XMLSchema#string

P2860

Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Cerebral microbleeds: a guide to detection and interpretation.

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.

Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study.

Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?

Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage.

Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage.

Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study.

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

P304

1492-1494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.114.004130

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Charles DeCarli

P577

2014-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261515398

http://www.w3.org/2001/XMLSchema#string

P698

24713533

http://www.w3.org/2001/XMLSchema#string

P932

4048617

http://www.w3.org/2001/XMLSchema#string